Contact
Please use this form to send email to PR contact of this press release:
Vaccinex Details Scientific Rationale for Expanding Pepinemab Clinical Programs to Include Alzheimer’s Disease
TO:
Please use this form to send email to PR contact of this press release:
Vaccinex Details Scientific Rationale for Expanding Pepinemab Clinical Programs to Include Alzheimer’s Disease
TO: